Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (66001) 66001
Newspaper Article (10445) 10445
Newsletter (5706) 5706
Book Chapter (907) 907
Magazine Article (431) 431
Web Resource (145) 145
Trade Publication Article (119) 119
Transcript (90) 90
Book / eBook (74) 74
Dissertation (37) 37
Conference Proceeding (27) 27
Government Document (19) 19
Report (17) 17
Book Review (11) 11
Reference (9) 9
Paper (7) 7
Streaming Video (4) 4
Journal / eJournal (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47557) 47557
science & technology (46815) 46815
life sciences & biomedicine (43730) 43730
hepatitis (32663) 32663
male (27033) 27033
female (25525) 25525
adult (20829) 20829
middle aged (20375) 20375
hepatitis b (16919) 16919
hepatitis c (16491) 16491
gastroenterology & hepatology (15515) 15515
infectious diseases (14794) 14794
antiviral agents - therapeutic use (14708) 14708
hepatitis c virus (13741) 13741
health aspects (12372) 12372
biological and medical sciences (12337) 12337
medical sciences (11915) 11915
infections (10862) 10862
interferon (10021) 10021
aged (9568) 9568
hepatitis b virus (9343) 9343
antiviral agents (9281) 9281
liver (9241) 9241
research (9117) 9117
treatment outcome (9072) 9072
drug therapy (8550) 8550
liver diseases (8192) 8192
care and treatment (8015) 8015
hepatitis c, chronic - drug therapy (7954) 7954
patients (7591) 7591
risk factors (7583) 7583
virology (7483) 7483
viruses (7444) 7444
viral diseases (7235) 7235
medical research (6452) 6452
analysis (6444) 6444
human viral diseases (6419) 6419
viral hepatitis (6260) 6260
drug therapy, combination (6026) 6026
hepatitis b, chronic - drug therapy (6013) 6013
interferon-alpha - therapeutic use (5893) 5893
hepacivirus - genetics (5737) 5737
genotype (5649) 5649
virus diseases (5648) 5648
human immunodeficiency virus--hiv (5301) 5301
animals (5288) 5288
adolescent (5285) 5285
immunology (5283) 5283
liver cancer (5018) 5018
medicine, experimental (4918) 4918
hepatitis c - drug therapy (4843) 4843
medicine (4808) 4808
hiv (4785) 4785
abridged index medicus (4712) 4712
pharmacology & pharmacy (4572) 4572
pharmacology. drug treatments (4545) 4545
liver cirrhosis (4524) 4524
clinical trials (4488) 4488
young adult (4435) 4435
microbiology (4405) 4405
retrospective studies (4358) 4358
hepatology (4092) 4092
hepatitis b virus - genetics (4060) 4060
studies (4047) 4047
ribavirin - therapeutic use (4029) 4029
oncology (3906) 3906
research article (3903) 3903
antigens (3836) 3836
hepatocellular carcinoma (3821) 3821
digestive system diseases (3770) 3770
proteins (3768) 3768
viral load (3714) 3714
antiviral agents - administration & dosage (3678) 3678
biological response modifiers (3563) 3563
ribavirin (3493) 3493
hepatitis b - drug therapy (3487) 3487
genetic aspects (3463) 3463
general & internal medicine (3453) 3453
recombinant proteins (3435) 3435
medicine, general & internal (3396) 3396
gastroenterology and hepatology (3316) 3316
antiviral agents - adverse effects (3294) 3294
mortality (3276) 3276
hepatitis c - complications (3241) 3241
medicine & public health (3214) 3214
transplantation (3207) 3207
cirrhosis (3203) 3203
pharmaceutical industry (3163) 3163
hepacivirus - drug effects (3152) 3152
time factors (3145) 3145
drug dosages (3131) 3131
hepatitis c, chronic - complications (3067) 3067
antiviral agents - pharmacology (3055) 3055
deoxyribonucleic acid--dna (3017) 3017
liver - pathology (3012) 3012
liver transplantation (3007) 3007
hiv infections - complications (2998) 2998
science & technology - other topics (2993) 2993
cancer (2969) 2969
drugs (2950) 2950
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (21) 21
Online Resources - Online (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (81386) 81386
Chinese (933) 933
German (533) 533
French (463) 463
Russian (362) 362
Spanish (350) 350
Portuguese (331) 331
Japanese (326) 326
Korean (199) 199
Polish (140) 140
Italian (132) 132
Hungarian (62) 62
Turkish (38) 38
Czech (30) 30
Dutch (30) 30
Croatian (26) 26
Romanian (22) 22
Ukrainian (17) 17
Danish (16) 16
Norwegian (16) 16
Serbian (12) 12
Hebrew (7) 7
Urdu (7) 7
Swedish (5) 5
Persian (4) 4
Slovak (4) 4
Finnish (3) 3
Bulgarian (2) 2
Albanian (1) 1
Arabic (1) 1
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
by Reddy, K. Rajender and Beavers, Kimberly L and Hammond, Sarah P and Lim, Joseph K and Falck-Ytter, Yngve T and American Gastroenterological Association Institute
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 215 - 219
Gastroenterology and Hepatology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recurrence | Antiviral Agents - therapeutic use | Hepatitis B virus - pathogenicity | Humans | Hepatitis B - virology | Treatment Outcome | Biomarkers - blood | Viral Load | Hepatitis B Surface Antigens - blood | DNA, Viral - blood | Hepatitis B - diagnosis | Hepatitis B - immunology | Hepatitis B Antibodies - blood | Hepatitis B virus - drug effects | Virus Activation - drug effects | Hepatitis B - drug therapy | Hepatitis B virus - genetics | Immunosuppressive Agents - adverse effects | Hepatitis B - prevention & control | Hepatitis B virus - immunology | Prevention | Practice guidelines (Medicine) | Medical colleges | Hepatitis B | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
by Perrillo, Robert P and Gish, Robert and Falck-Ytter, Yngve T
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 221 - 244.e3
Gastroenterology and Hepatology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Recurrence | Antiviral Agents - therapeutic use | Hepatitis B virus - pathogenicity | Humans | Risk Factors | Hepatitis B - virology | Treatment Outcome | Biomarkers - blood | Viral Load | Hepatitis B Surface Antigens - blood | DNA, Viral - blood | Hepatitis B - diagnosis | Hepatitis B - immunology | Hepatitis B Antibodies - blood | Hepatitis B virus - drug effects | Societies, Medical | Virus Activation - drug effects | Gastroenterology | Hepatitis B - drug therapy | Hepatitis B virus - genetics | Immunosuppressive Agents - adverse effects | Hepatitis B - prevention & control | Hepatitis B virus - immunology | Prevention | Continuing medical education | Hepatitis B | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Hepatitis B therapy
by Kwon, Hellan and Lok, Anna S
Nature reviews. Gastroenterology & hepatology, ISSN 1759-5045, 05/2011, Volume 8, Issue 5, pp. 275 - 284
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Nucleosides - therapeutic use | Hepatitis B, Chronic - immunology | Antiviral Agents - therapeutic use | Humans | Drug Resistance, Viral | Interferon-alpha - therapeutic use | Treatment Outcome | Recombinant Proteins | Polyethylene Glycols - therapeutic use | Hepatitis B, Chronic - drug therapy | Antiviral Agents - adverse effects | Hepatitis B, Chronic - physiopathology | Hepatitis B e Antigens - blood | Antiviral agents | Usage | Research | Drug resistance | Drug therapy | Health aspects | Risk factors | Hepatitis B | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Off‐therapy durability of response to entecavir therapy in hepatitis B e antigen‐negative chronic hepatitis B patients
by Jeng, Wen‐Juei and Sheen, I‐Shyan and Chen, Yi‐Cheng and Hsu, Chao‐Wei and Chien, Rong‐Nan and Chu, Chia‐Ming and Liaw, Yun‐Fan
Hepatology (Baltimore, Md.), ISSN 0270-9139, 12/2013, Volume 58, Issue 6, pp. 1888 - 1896
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Cirrhosis - drug therapy | Recurrence | Prospective Studies | Guanine - analogs & derivatives | Humans | Middle Aged | Male | Treatment Outcome | Alanine Transaminase - blood | DNA, Viral - blood | Hepatitis B, Chronic - drug therapy | Hepatitis B virus - genetics | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Hepatitis B e Antigens - blood | Cohort Studies | Guanine - administration & dosage | Hepatitis | Consolidation | Liver cirrhosis | Hepatology | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action
by Tan, W.S. Daniel and Liao, Wupeng and Zhou, Shuo and Wong, W.S. Fred
Biochemical pharmacology, ISSN 0006-2952, 09/2017, Volume 139, pp. 71 - 81
Hepatitis | NF-κB | Autoimmune | Neurodegeneration | Nrf2 | Asthma | Liver Cirrhosis - immunology | Humans | Drugs, Investigational - therapeutic use | NF-E2-Related Factor 2 - agonists | Protective Agents - chemistry | Neurodegenerative Diseases - drug therapy | Hepatitis - drug therapy | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Hepatitis - metabolism | Pneumonia - immunology | Autoimmune Diseases - metabolism | Autoimmune Diseases - drug therapy | Diterpenes - pharmacology | Chemical and Drug Induced Liver Injury - prevention & control | NF-kappa B p50 Subunit - antagonists & inhibitors | NF-kappa B p50 Subunit - metabolism | Autoimmune Diseases - prevention & control | Chemical and Drug Induced Liver Injury - immunology | Signal Transduction - drug effects | Chemical and Drug Induced Liver Injury - metabolism | Models, Biological | NF-E2-Related Factor 2 - metabolism | Oxidative Stress - drug effects | Pneumonia - metabolism | Drugs, Investigational - adverse effects | Drugs, Investigational - pharmacology | Dermatitis - immunology | Neurodegenerative Diseases - prevention & control | Protective Agents - metabolism | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors | Protective Agents - therapeutic use | Neurodegenerative Diseases - immunology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Drugs, Investigational - chemistry | Hepatitis - prevention & control | Drug Design | Liver Cirrhosis - metabolism | Diterpenes - chemistry | Liver Cirrhosis - drug therapy | Diterpenes - therapeutic use | Liver Cirrhosis - prevention & control | Autoimmune Diseases - immunology | Dermatitis - prevention & control | Neurodegenerative Diseases - metabolism | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Pneumonia - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | NF-kappa B p50 Subunit - chemistry | Hepatitis - immunology | Diterpenes - adverse effects | Dermatitis - drug therapy | Dermatitis - metabolism | Antioxidants | Medical colleges | Lead compounds | Drug discovery | Anti-inflammatory drugs | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Hepatitis B virus reactivation associated with direct-acting antiviral therapy for chronic hepatitis C virus: A review of cases reported to the U.S. Food and drug administration adverse event reporting system
by Bersoff-Matcha, Susan J and Cao, Kelly and Jason, Mihaela and Ajao, Adebola and Jones, S. Christopher and Meyer, Tamra and Brinker, Allen
Annals of internal medicine, ISSN 0003-4819, 06/2017, Volume 166, Issue 11, pp. 792 - 798
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Coinfection | Antiviral Agents - therapeutic use | United States | Humans | Middle Aged | Hepatitis B - virology | Hepatitis C, Chronic - virology | Male | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Hepatitis B virus - physiology | Hepatitis B - complications | Antiviral Agents - adverse effects | Aged, 80 and over | Adult | Female | Aged | Virus Activation | Chemical and Drug Induced Liver Injury - etiology | United States Food and Drug Administration | Antiviral agents | Medical research | Medicine, Experimental | Transplantation of organs, tissues, etc | Hepatitis B virus | Hepatitis C virus | Health aspects | Risk factors | Hepatitis B | Prevention | Dosage and administration | Research | Hepatitis C | Drug therapy | Hepatitis | Side effects | Antiviral drugs | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
by Li, Guangdi and De Clercq, Erik
Nature reviews. Drug discovery, ISSN 1474-1776, 03/2020, Volume 19, Issue 3, pp. 149 - 150
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Betacoronavirus - pathogenicity | Recombinant Proteins - therapeutic use | Interferon-alpha - pharmacology | Alanine - therapeutic use | Hepatitis C - drug therapy | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Polyethylene Glycols - therapeutic use | COVID-19 | Alanine - analogs & derivatives | Protease Inhibitors - pharmacology | SARS-CoV-2 | SARS Virus - genetics | Nucleosides - pharmacology | Spike Glycoprotein, Coronavirus - drug effects | Influenza, Human - drug therapy | Protease Inhibitors - therapeutic use | Polyethylene Glycols - pharmacology | Nucleosides - therapeutic use | Antiviral Agents - therapeutic use | Betacoronavirus - drug effects | Interferon-alpha - therapeutic use | Middle East Respiratory Syndrome Coronavirus - drug effects | SARS Virus - drug effects | Drug Repositioning | Recombinant Proteins - pharmacology | Adenosine Monophosphate - therapeutic use | SARS Virus - pathogenicity | Middle East Respiratory Syndrome Coronavirus - pathogenicity | Middle East Respiratory Syndrome Coronavirus - genetics | Adenosine Monophosphate - analogs & derivatives | Hepatitis B - drug therapy | HIV Infections - drug therapy | Betacoronavirus - genetics | Antiviral agents | Pharmacology, Experimental | Physiological aspects | Drug targeting | Genetic aspects | Research | Coronaviruses | Clinical trials | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta‐analysis
by Chen, Guofeng and Wang, Cheng and Chen, Jing and Ji, Dong and Wang, Yudong and Wu, Vanessa and Karlberg, Johan and Lau, George
Hepatology (Baltimore, Md.), ISSN 0270-9139, 07/2017, Volume 66, Issue 1, pp. 13 - 26
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hepacivirus - drug effects | Prognosis | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Humans | Male | Treatment Outcome | Hepatitis B, Chronic - diagnosis | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Coinfection - virology | Hepatitis B virus - drug effects | Hepatitis B, Chronic - drug therapy | Virus Activation - drug effects | Female | Drug Therapy, Combination | Antiviral agents | Hepatitis | Hepatitis B surface antigen | Infections | Interferon | Hepatitis C | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Hepatitis B virus reverse transcriptase – Target of current antiviral therapy and future drug development
by Clark, Daniel N and Hu, Jianming
Antiviral research, ISSN 0166-3542, 11/2015, Volume 123, pp. 132 - 137
Reverse transcriptase | HBV | Antiviral therapies | Protein priming | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Virology | Hepatitis B virus - enzymology | Reverse Transcriptase Inhibitors - isolation & purification | Antiviral Agents - pharmacology | RNA-Directed DNA Polymerase - metabolism | Humans | Drug Discovery - trends | Reverse Transcriptase Inhibitors - pharmacology | Drug Discovery - methods | Antiviral Agents - isolation & purification | DNA polymerases | Antiviral agents | DNA synthesis | Hepatitis B | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights